Yılmaz, T. Et Al. 2023. RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE?. ESPGHAN 55th Annual Meeeting , (Vienna, Austria), 915.

Yılmaz, T., Leblebici, U. C., Önal, Z., Sağ, E., Tuğcu, D., Yücel, E., ... Durmaz, Ö.(2023). RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE? . ESPGHAN 55th Annual Meeeting (pp.915). Vienna, Austria

Yılmaz, Tuğçe Et Al. "RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE?," ESPGHAN 55th Annual Meeeting, Vienna, Austria, 2023

Yılmaz, Tuğçe Et Al. "RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE?." ESPGHAN 55th Annual Meeeting , Vienna, Austria, pp.915, 2023

Yılmaz, T. Et Al. (2023) . "RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE?." ESPGHAN 55th Annual Meeeting , Vienna, Austria, p.915.

@conferencepaper{conferencepaper, author={Tuğçe Yılmaz Et Al. }, title={RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE?}, congress name={ESPGHAN 55th Annual Meeeting}, city={Vienna}, country={Austria}, year={2023}, pages={915} }